MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $631,184 | +52.9% | 14,490 | +26.9% | 0.01% | +66.7% |
| Q2 2023 | $412,677 | -5.0% | 11,422 | -2.2% | 0.00% | -25.0% |
| Q1 2023 | $434,262 | -12.7% | 11,680 | +6.3% | 0.00% | -20.0% |
| Q4 2022 | $497,685 | -32.6% | 10,984 | +4.0% | 0.01% | -37.5% |
| Q3 2022 | $738,000 | +4.4% | 10,563 | +0.4% | 0.01% | +14.3% |
| Q2 2022 | $707,000 | -17.7% | 10,526 | +0.7% | 0.01% | 0.0% |
| Q1 2022 | $859,000 | -39.8% | 10,448 | +7.4% | 0.01% | -36.4% |
| Q4 2021 | $1,427,000 | -17.8% | 9,726 | -0.8% | 0.01% | -21.4% |
| Q3 2021 | $1,735,000 | +11.5% | 9,808 | +1.8% | 0.01% | +7.7% |
| Q2 2021 | $1,556,000 | -11.3% | 9,635 | -6.0% | 0.01% | -13.3% |
| Q1 2021 | $1,755,000 | -4.8% | 10,246 | +22.0% | 0.02% | -11.8% |
| Q4 2020 | $1,844,000 | +29.8% | 8,396 | -1.9% | 0.02% | +21.4% |
| Q3 2020 | $1,421,000 | +95.2% | 8,559 | +34.2% | 0.01% | +40.0% |
| Q2 2020 | $728,000 | +57.2% | 6,379 | +6.0% | 0.01% | +25.0% |
| Q1 2020 | $463,000 | – | 6,018 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |